← Eichor
Study identifier: NCT07147569 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

TAMBE Japan Post-Marketing Surveillance

Condition: Thoracoabdominal Aortic Aneurysm · Pararenal Aortic Aneurysm  ·  Sponsor: W.L.Gore & Associates

PhaseN/A
Planned participants100
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersNo

About this study

To evaluate the safety and efficacy of multi component system (TAMBE device) including GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis (Aortic Component; AC) under post-marketing use.

This description comes directly from the study's public registry record.

Talk to the study team

Katsuyuki Niwa  ·  +819017754499  ·  kniwa@wlgore.com

Always discuss trial participation with your own doctor first.

Locations (5)

The Jikei University HospitalMinatoku, JapanRecruiting
Nagoya University HospitalNagoya, JapanRecruiting
Morinomiya HospitalOsaka, JapanRecruiting
Osaka International Medical & Science Center Osaka Police HospitalOsaka, JapanRecruiting
The University of Osaka HospitalSuita, JapanRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07147569